ST Germain D J Co. Inc. Boosts Stake in Danaher Corporation (DHR)

ST Germain D J Co. Inc. lifted its position in shares of Danaher Corporation (NYSE:DHR) by 5.8% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,630 shares of the conglomerate’s stock after buying an additional 691 shares during the quarter. ST Germain D J Co. Inc.’s holdings in Danaher Corporation were worth $1,083,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. GQG Partners LLC bought a new position in shares of Danaher Corporation in the second quarter worth $101,000. Proficio Capital Partners LLC increased its position in shares of Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 598 shares during the period. Monetary Management Group Inc. increased its position in shares of Danaher Corporation by 10.7% in the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after purchasing an additional 150 shares during the period. Acrospire Investment Management LLC increased its position in shares of Danaher Corporation by 185.5% in the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after purchasing an additional 1,100 shares during the period. Finally, ClariVest Asset Management LLC bought a new position in shares of Danaher Corporation in the first quarter worth $157,000. 75.38% of the stock is owned by institutional investors.

Shares of Danaher Corporation (NYSE DHR) opened at $93.30 on Friday. The firm has a market capitalization of $64,899.95, a PE ratio of 23.98, a PEG ratio of 2.22 and a beta of 1.02. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. Danaher Corporation has a twelve month low of $76.27 and a twelve month high of $93.86.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.87 earnings per share. research analysts anticipate that Danaher Corporation will post 3.99 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend was Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is currently 16.52%.

In other news, Director Donald J. Ehrlich sold 10,578 shares of the business’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total transaction of $960,693.96. Following the sale, the director now directly owns 104,621 shares in the company, valued at $9,501,679.22. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider William King sold 43,688 shares of the business’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $82.86, for a total value of $3,619,987.68. Following the sale, the insider now owns 45,748 shares in the company, valued at $3,790,679.28. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 317,498 shares of company stock worth $28,838,801. Company insiders own 12.20% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “ST Germain D J Co. Inc. Boosts Stake in Danaher Corporation (DHR)” was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://sportsperspectives.com/2017/11/19/st-germain-d-j-co-inc-boosts-stake-in-danaher-corporation-dhr.html.

DHR has been the topic of a number of recent analyst reports. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. BidaskClub cut Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Jefferies Group LLC restated a “buy” rating and issued a $95.00 price target on shares of Danaher Corporation in a research report on Friday, August 4th. Finally, J P Morgan Chase & Co restated an “overweight” rating and issued a $95.00 price target on shares of Danaher Corporation in a research report on Friday, September 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $93.31.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply